Adiponectin has also been shown to be significant in Alzheimer’s disease (AD), as it stimulates insulin sensitivity, exhibits anti-inflammatory and antioxidant effects, and protects against the production of amyloid beta and Tau protein phosphorylation caused by decreased cerebral insulin signaling activities [67]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.